Biofrontera Inc. (BFRI)
USD 0.81
(0.32%)
USD 0.81
(0.32%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 10.9 Million USD | 52.18% |
| 2022 | 7.16 Million USD | 60.79% |
| 2021 | 4.45 Million USD | -37.13% |
| 2020 | 7.09 Million USD | -32.34% |
| 2019 | 10.48 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 3.94 Million USD | -42.85% |
| 2024 Q1 | 6.9 Million USD | -36.7% |
| 2023 Q4 | 10.9 Million USD | -32.11% |
| 2023 FY | 10.9 Million USD | 52.18% |
| 2023 Q3 | 16.06 Million USD | 8.68% |
| 2023 Q2 | 14.78 Million USD | 121.66% |
| 2023 Q1 | 6.67 Million USD | -6.95% |
| 2022 Q2 | 8.8 Million USD | 80.79% |
| 2022 Q1 | 4.87 Million USD | 9.29% |
| 2022 FY | 7.16 Million USD | 60.79% |
| 2022 Q4 | 7.16 Million USD | -40.7% |
| 2022 Q3 | 12.08 Million USD | 37.23% |
| 2021 Q2 | 6.71 Million USD | -20.25% |
| 2021 Q4 | 4.45 Million USD | -18.04% |
| 2021 Q3 | 5.43 Million USD | -19.05% |
| 2021 FY | 4.45 Million USD | -37.13% |
| 2021 Q1 | 8.42 Million USD | 18.81% |
| 2020 FY | 7.09 Million USD | -32.34% |
| 2020 Q4 | 7.09 Million USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2019 FY | 10.48 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Bright Green Corporation | - USD | -Infinity% |
| Alpha Teknova, Inc. | 11.59 Million USD | 5.917% |
| ANI Pharmaceuticals, Inc. | 111.19 Million USD | 90.19% |
| Aquestive Therapeutics, Inc. | 6.76 Million USD | -61.146% |
| Collegium Pharmaceutical, Inc. | 32.33 Million USD | 66.263% |
| Cosmos Health Inc. | 4.78 Million USD | -127.769% |
| Journey Medical Corporation | 10.2 Million USD | -6.878% |
| Embecta Corp. | 152.1 Million USD | 92.828% |
| Esperion Therapeutics, Inc. | 65.62 Million USD | 83.378% |
| Dynavax Technologies Corporation | 53.29 Million USD | 79.531% |
| Intra-Cellular Therapies, Inc. | 11.64 Million USD | 6.345% |
| Pacira BioSciences, Inc. | 104.35 Million USD | 89.547% |
| PainReform Ltd. | - USD | -Infinity% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -90.209% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -90.209% |
| SCYNEXIS, Inc. | - USD | -Infinity% |
| Safety Shot Inc | 1.86 Million USD | -483.426% |
| China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -1247.071% |
| Procaps Group, S.A. | 96.83 Million USD | 88.735% |
| Theratechnologies Inc. | 6.06 Million USD | -79.822% |
| Harrow Health, Inc. | 10.86 Million USD | -0.377% |
| Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -301.177% |
| DURECT Corporation | 2.21 Million USD | -391.573% |
| Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 85.908% |
| Cronos Group Inc. | 30.33 Million USD | 64.046% |
| OptiNose, Inc. | 8.05 Million USD | -35.469% |
| Ironwood Pharmaceuticals, Inc. | 1.00 USD | -1090799900.0% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| RedHill Biopharma Ltd. | 5.69 Million USD | -91.401% |
| Organogenesis Holdings Inc. | 28.25 Million USD | 61.392% |
| Guardion Health Sciences, Inc. | 2.67 Million USD | -307.454% |
| Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -136.649% |
| Radius Health, Inc. | 278.64 Million USD | 96.085% |
| Universe Pharmaceuticals INC | 3.34 Million USD | -226.268% |
| ProPhase Labs, Inc. | 3.84 Million USD | -183.989% |
| Phibro Animal Health Corporation | 265.91 Million USD | 95.898% |
| Procaps Group S.A. | 96.83 Million USD | 88.735% |
| Alvotech | 74.43 Million USD | 85.345% |
| TherapeuticsMD, Inc. | - USD | -Infinity% |
| Viatris Inc. | 3.46 Billion USD | 99.686% |
| Rockwell Medical, Inc. | 5.87 Million USD | -85.795% |
| Aytu BioPharma, Inc. | 12.63 Million USD | 13.655% |
| SIGA Technologies, Inc. | 64.21 Million USD | 83.014% |
| Tilray Brands, Inc. | 252.08 Million USD | 95.673% |
| Lifecore Biomedical, Inc. | 39.97 Million USD | 72.716% |
| Shineco, Inc. | 1.58 Million USD | -586.675% |
| PetIQ, Inc. | 159.3 Million USD | 93.153% |
| Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 7239.771% |
| Incannex Healthcare Limited | -10.01 Million USD | 208.917% |
| Neurocrine Biosciences, Inc. | 38.3 Million USD | 71.52% |
| Alimera Sciences, Inc. | 1.87 Million USD | -480.522% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 37.68 Million USD | 71.056% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Petros Pharmaceuticals, Inc. | 1.61 Million USD | -577.351% |
| Clever Leaves Holdings Inc. | 4.48 Million USD | -143.319% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -4188.545% |
| Avadel Pharmaceuticals plc | 10.38 Million USD | -5.087% |
| Hempacco Co., Inc. | 2.54 Million USD | -329.005% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 74.43 Million USD | 85.345% |
| Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 77.177% |
| Lantheus Holdings, Inc. | 64.02 Million USD | 82.964% |
| Currenc Group, Inc. | 732.91 Thousand USD | -1388.312% |
| Kamada Ltd. | 87.74 Million USD | 87.569% |
| Indivior PLC | 141.79 Million USD | 92.307% |
| Evoke Pharma, Inc. | 481.84 Thousand USD | -2163.822% |
| Flora Growth Corp. | 8.5 Million USD | -28.209% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -4188.545% |
| Evolus, Inc. | 10.99 Million USD | 0.818% |
| HUTCHMED (China) Limited | 50.25 Million USD | 78.296% |
| Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 89.693% |
| Akanda Corp. | 1.28 Million USD | -747.622% |